RATIONALE: Food allergy is common, although allergic symptoms can sometimes be produced by skin contact or inhalation of volatile food antigens. Exposure to these allergens is also relatively common in nonoccupationally settings, such as the home. We present a case of food allergy to Swiss chard. METHODS: Total and specific IgE (sIgE) were determined by ImmunoCAPÒ and ImmunoCAPÒ ISAC 112. Skin prick tests, SDS-PAGE and Immunoblotting with extract of leaf and stem of Swiss chard were carried out. Protein sequencing was analysed by mass spectrometry. RESULTS: Prick were positive to extracts from D. pteronyssinus, dog epithelium, pollens from P. pratense, P. lanceolata and O. europaea, spinach, carrot and chard. Prick by prick with cooked and raw chard and apple peel were also positive. Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA. RATIONALE: Patients with chronic idiopathic urticaria are frequently concerned about an association with underlying allergic disease. There is limited data on allergy risk factors for chronic urticaria in adults. This study aimed to determine the prevalence of co-existing allergic and the role of atopic disease in health care utilization (HCU) in adult patients with chronic idiopathic urticaria (IU) and co-morbid urticaria/angioedema (CUA). METHODS: We retrospectively reviewed patients with chronic urticaria (IU and CUA) seen in a university allergy immunology clinic from September 2007-2017 and analyzed the frequency of reported allergic rhinitis/conjunctivitis (AR/AC), atopic dermatitis (AD) and family history of atopic disease. We further analyzed the HCU measured by ER visits and systemic corticosteroid (sCS) use in this patient population. RESULTS: We analyzed 362 patients (223 had CUA, 139 had IU). Overall, 7% reported AD and 44% reported AR/AC. There was no difference in prevalence of AD or AR/AC in IU vs. CUA groups (p50.71, p50.32, respectively). In those with co-existing allergic disease, there was no difference in HCU vs. those without allergic disease (p50.92 (ER), p50.23 (sCS), for AD; p50.67 (ER), p50.97 (sCs, for AR/AC). Family history of atopy was noted in 19% of urticaria patients. There were no difference HCU in patients with and without family history of atopy. CONCLUSIONS: Our study demonstrates a high prevalence of allergic disease in adults with chronic urticaria. However, the co-existence of allergic disease or family history of atopy does not increase HCU. Further studies are needed to determine the underlying mechanism of chronic urticaria in adults. Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA. RATIONALE: While allergic reactions to drugs can be a cause of acute urticaria and angioedema, the frequency of patient-reported drug allergies in chronic urticaria and angioedema has not been explored. The prevalence of adverse drug reactions in the general population is 7%. We aim to determine the prevalence of patient-reported drug allergies in patients with chronic urticaria and/or angioedema. We hypothesize that prevalence of reported drug allergies in this population will be higher than the general population. METHODS: We retrospectively identified patients with chronic idiopathic urticaria and angioedema seen in a university allergy immunology clinic from September 2007-2017. We classified patients as comorbid urticaria and angioedema (CUA), isolated urticaria (IU), or isolated angioedema (IA) and collected data on patient-reported drug allergies. Patients with ACE-inhibitor induced angioedema were excluded from analysis. RESULTS: 451 patients with urticaria and/or angioedema were identified. Drug allergies were reported in 62% (n5280). Patients who reported drug allergies were older (median 47 vs. 36 years, p<0.001) and had higher BMI (median 28.3 vs. 26.6, p50.002). There was no difference by gender (p5 0.57). Patients with IA had the highest frequency of reported drug allergy (76%), significantly higher than CUA (60%) and IU (57%) (overall p50.007). Allergy to >1 drug was reported in 171 patients (38%). The frequency of multiple drug allergy did not differ by subgroup (p50.26). CONCLUSIONS: Our study suggests that patients with idiopathic urticaria and/or angioedema have a much higher reported frequency of drug allergy than the general population. Further studies are needed to explore these findings.
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